U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07222592) titled 'MOBoxy: MoblO2 to Maintain Oxygenation' on Oct. 20.
Brief Summary: Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of the following: 1) that it will limit desaturation events and combat breathlessness, thus preventing the frustratingly slow pace and numerous rest breaks patients are forced to adopt while doing even simple tasks; 2) that it will allow patients to be more active physically (perhaps increase t...